세계의 생물학적 제제 아웃소싱 시장 보고서(2025년)

Biologics outsourcing in the pharmaceutical industry involves pharmaceutical companies collaborating with external vendors or contract manufacturing organizations (CMOs) to delegate different aspects of biologic drug development, manufacturing, and supply chain management. This strategic approach is employed for various purposes within the pharmaceutical sector, specifically in relation to the development, manufacturing, and management of biological drugs.

The primary product types associated with biologics outsourcing include antibodies, recombinants, vaccines, proteins, and others. Antibodies are immune system-produced defense proteins, also known as antigens, formed in response to the presence of foreign material. These biologics can be derived from human, microbial, and other sources and find applications in areas such as oncology, cellular and gene therapy, blood and blood-related product development, vaccine development, stem cell research, among others. Biologics outsourcing is utilized by diverse end users, including pharmaceutical industries, biotechnology industries, and contract development and manufacturing organizations (CDMO).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biologics outsourcing market research report is one of a series of new reports from The Business Research Company that provides biologics outsourcing market statistics, including the biologics outsourcing industry's global market size, regional shares, competitors with a biologics outsourcing market share, detailed biologics outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the biologics outsourcing industry. This biologics outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologics outsourcing market size has grown rapidly in recent years. It will grow from $20.06 billion in 2024 to $22.58 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing R&D costs, regulatory pressure, demand for specialized expertise, globalization.

The biologics outsourcing market size is expected to see rapid growth in the next few years. It will grow to $37.28 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to emerging markets' growth, personalized medicine, strategic alliances, biological drug patent expirations. Major trends in the forecast period include advancements in technology, increased outsourcing complexity, biosimilars market expansion, data analytics integration, supply chain resilience.

The forecast of 13.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. biopharma by increasing costs for fill-finish services and stability testing imported from South Korea and Italy, potentially delaying biologics manufacturing and raising production expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The biologics outsourcing market is poised for growth, driven by the increasing number of cancer cases. Cancer, a diverse group of illnesses characterized by uncontrolled cell growth, demands specialized expertise and resources for developing biologic therapies such as monoclonal antibodies and immunotherapies. Biologics outsourcing is integral in providing the necessary infrastructure for the development, manufacturing, and clinical supply of these therapies, crucial for diagnosing and treating various cancer types. For instance, the National Center for Biotechnology Information reported 1,958,310 new cancer cases in the United States in January 2023, with a projected 609,820 cancer-related deaths. The prevalence of cancer is expected to escalate to 29.5 million new cases and 16.4 million deaths by 2040, emphasizing the role of biologics outsourcing in addressing the growing challenges posed by cancer.

The biologics outsourcing market is anticipated to be supported by the rise in chronic diseases and disabilities. Chronic conditions necessitate ongoing medical attention, and biologics prove effective in managing such complex health issues. Pharmaceutical and biotechnology companies are increasingly turning to outsourcing for specialized expertise in developing targeted treatments. The National Library of Medicine estimates a 99.5% increase in people aged 50 and older with at least one chronic illness, reaching 142.66 million in 2050. Additionally, the number of individuals with multimorbidity is projected to rise by 91.16% to 14.968 million in 2050. This surge in chronic diseases underscores the significance of biologics outsourcing in meeting the demands of intricate medical conditions.

A notable trend in the biologics outsourcing market is the emphasis on developments in biologics. Major companies are leveraging new technologies to sustain their market positions. For instance, Abzena, Alira Health, and Oncodesign launched DRIVE-Biologics, a consortium dedicated to biologic drug discovery and development programs. This collaborative effort streamlines information sharing and program deliverables, minimizing risks associated with biologics development. The partnership covers all stages, from biological discovery to clinical and commercial manufacturing, reflecting the commitment to advancing the field of biologics.

Companies in the biologics outsourcing market are focusing on establishing new Contract Development and Manufacturing Organizations (CDMOs) to maintain their market presence. Tanvex BioPharma USA Inc. introduced Tanvex CDMO in October 2023, offering end-to-end services for the development and manufacturing of biologics. Located in San Diego's biotech hub, Tanvex CDMO features state-of-the-art facilities, including R&D centers, GMP manufacturing suites, QC laboratories, and a GMP warehouse. With a proven track record, Tanvex CDMO aims to support early-stage companies in advancing biologics from conceptualization to commercialization.

In June 2022, Asahi Kasei Medical acquired Bionova Scientific LLC, expanding its bioprocess business to include biopharmaceutical contract development and manufacturing. Bionova Scientific LLC, a biologics CDMO, enhances Asahi Kasei Medical's capabilities in biologic drug development, manufacturing, and supply chain management, contributing to the broader landscape of biologics outsourcing.

Major companies operating in the biologics outsourcing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Lonza Group Ag, Catalent Inc., Sartorius Stedim Biotech S.A., Charles River Laboratories International Inc., WuXi Biologics Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., CordenPharma GmbH, Ajinomoto Bio-Pharma Services, Syngene International Limited, Rentschler Biopharma SE, Albany Molecular Research Inc., KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies Inc., Avid Bioservices Inc., BioVectra Inc., ProBioGen AG, ABL Inc., Vibalogics GmbH, JHL Biotech Inc., Goodwin Biotechnology Inc., Crown Bioscience Inc., Cytovance Biologics Inc., LakePharma Inc., AGC Biologics GmbH, Biomay AG, Polpharma Biologics S.A.

North America was the largest region in the biologics outsourcing market in 2024. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biologics outsourcing market includes revenues earned by entities through cell line development, contract research services, and optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologics outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Antibodies; Recombinant; Vaccines; Protein; Other Products
• 2) By Source: Human; Microbial; Other Source
• 3) By Application: Oncology; Cellular And Gene Therapy; Blood And Blood-Related Products Development; Vaccine Development; Stem Cell Research; Other Applications
• 4) By End User: Pharmaceutical Industries; Biotechnology Industries; Contract Development And Manufacturing Organization(CDMO)
• Subsegments:
• 1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies
• 2) By Recombinant: Recombinant Proteins; Recombinant DNA Products
• 3) By Vaccines: Therapeutic Vaccines; Preventive Vaccines
• 4) By Protein: Enzymes; Hormones; Cytokines
• 5) By Other Products: Gene Therapies; Cell Therapies; Biosimilars
• Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Boehringer Ingelheim GmbH; Lonza Group Ag; Catalent Inc.; Sartorius Stedim Biotech S.A.; Charles River Laboratories International Inc.; WuXi Biologics Inc.; Samsung Biologics Co. Ltd.; Emergent BioSolutions Inc.; CordenPharma GmbH; Ajinomoto Bio-Pharma Services; Syngene International Limited; Rentschler Biopharma SE; Albany Molecular Research Inc.; KBI Biopharma Inc.; Fujifilm Diosynth Biotechnologies Inc.; Avid Bioservices Inc.; BioVectra Inc.; ProBioGen AG; ABL Inc.; Vibalogics GmbH; JHL Biotech Inc.; Goodwin Biotechnology Inc.; Crown Bioscience Inc.; Cytovance Biologics Inc.; LakePharma Inc.; AGC Biologics GmbH; Biomay AG; Polpharma Biologics S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Outsourcing Market Characteristics

3. Biologics Outsourcing Market Trends And Strategies

4. Biologics Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biologics Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biologics Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biologics Outsourcing Market Growth Rate Analysis
• 5.4. Global Biologics Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biologics Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biologics Outsourcing Total Addressable Market (TAM)

6. Biologics Outsourcing Market Segmentation

• 6.1. Global Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Recombinant
• Vaccines
• Protein
• Other Products
• 6.2. Global Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human
• Microbial
• Other Source
• 6.3. Global Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cellular And Gene Therapy
• Blood And Blood-Related Products Development
• Vaccine Development
• Stem Cell Research
• Other Applications
• 6.4. Global Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Industries
• Biotechnology Industries
• Contract Development And Manufacturing Organization (CDMO)
• 6.5. Global Biologics Outsourcing Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.6. Global Biologics Outsourcing Market, Sub-Segmentation Of Recombinant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Proteins
• Recombinant DNA Products
• 6.7. Global Biologics Outsourcing Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Vaccines
• Preventive Vaccines
• 6.8. Global Biologics Outsourcing Market, Sub-Segmentation Of Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Hormones
• 6.9. Global Biologics Outsourcing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapies
• Cell Therapies
• Biosimilars

7. Biologics Outsourcing Market Regional And Country Analysis

• 7.1. Global Biologics Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biologics Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Outsourcing Market

• 8.1. Asia-Pacific Biologics Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Outsourcing Market

• 9.1. China Biologics Outsourcing Market Overview
• 9.2. China Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Outsourcing Market

• 10.1. India Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Outsourcing Market

• 11.1. Japan Biologics Outsourcing Market Overview
• 11.2. Japan Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Outsourcing Market

• 12.1. Australia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Outsourcing Market

• 13.1. Indonesia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Outsourcing Market

• 14.1. South Korea Biologics Outsourcing Market Overview
• 14.2. South Korea Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Outsourcing Market

• 15.1. Western Europe Biologics Outsourcing Market Overview
• 15.2. Western Europe Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Outsourcing Market

• 16.1. UK Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Outsourcing Market

• 17.1. Germany Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Outsourcing Market

• 18.1. France Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Outsourcing Market

• 19.1. Italy Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Outsourcing Market

• 20.1. Spain Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Outsourcing Market

• 21.1. Eastern Europe Biologics Outsourcing Market Overview
• 21.2. Eastern Europe Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Outsourcing Market

• 22.1. Russia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Outsourcing Market

• 23.1. North America Biologics Outsourcing Market Overview
• 23.2. North America Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Outsourcing Market

• 24.1. USA Biologics Outsourcing Market Overview
• 24.2. USA Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Outsourcing Market

• 25.1. Canada Biologics Outsourcing Market Overview
• 25.2. Canada Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Outsourcing Market

• 26.1. South America Biologics Outsourcing Market Overview
• 26.2. South America Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Outsourcing Market

• 27.1. Brazil Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Outsourcing Market

• 28.1. Middle East Biologics Outsourcing Market Overview
• 28.2. Middle East Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Outsourcing Market

• 29.1. Africa Biologics Outsourcing Market Overview
• 29.2. Africa Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Biologics Outsourcing Market Competitive Landscape
• 30.2. Biologics Outsourcing Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Outsourcing Market Other Major And Innovative Companies

• 31.1. Sartorius Stedim Biotech S.A.
• 31.2. Charles River Laboratories International Inc.
• 31.3. WuXi Biologics Inc.
• 31.4. Samsung Biologics Co. Ltd.
• 31.5. Emergent BioSolutions Inc.
• 31.6. CordenPharma GmbH
• 31.7. Ajinomoto Bio-Pharma Services
• 31.8. Syngene International Limited
• 31.9. Rentschler Biopharma SE
• 31.10. Albany Molecular Research Inc.
• 31.11. KBI Biopharma Inc.
• 31.12. Fujifilm Diosynth Biotechnologies Inc.
• 31.13. Avid Bioservices Inc.
• 31.14. BioVectra Inc.
• 31.15. ProBioGen AG

32. Global Biologics Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Outsourcing Market

34. Recent Developments In The Biologics Outsourcing Market

35. Biologics Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Biologics Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biologics Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biologics Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer